Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.35 |
| ▸ | DRD1 | P21728 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | DRD2 | P14416 | 4/20 | 0.33 |
| ▸ | DRD3 | P35462 | 4/20 | 0.33 |
| ▸ | DRD4 | P21917 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25675874 | 1.00 | ALDH1A1 (0.38) | ALDH1A1GAASLC6A2SLC6A4DRD1 | |
| SCHEMBL25659969 | 1.00 | ALDH1A1 (0.38) | ALDH1A1GAASLC6A2SLC6A4DRD1 | |
| SCHEMBL25659968 | 1.00 | ALDH1A1 (0.38) | ALDH1A1GAASLC6A2SLC6A4DRD1 | |
| SCHEMBL7305807 | 0.77 | ALDH1A1 (0.39) | ALDH1A1GAASLC6A2SLC6A4DRD1 | |
| SCHEMBL7234630 | 0.77 | ALDH1A1 (0.39) | ALDH1A1GAASLC6A2SLC6A4DRD1 | |
| SCHEMBL7305822 | 0.77 | ALDH1A1 (0.39) | ALDH1A1GAASLC6A2SLC6A4DRD1 | |
| SCHEMBL8517348 | 0.77 | SLC6A2 (0.38) | ALDH1A1GAASLC6A2SLC6A4DRD1 | |
| SCHEMBL25674510 | 0.77 | ALDH1A1 (0.33) | ALDH1A1GAASLC6A2SLC6A4DRD1 | |
| SCHEMBL25675865 | 0.77 | ALDH1A1 (0.33) | ALDH1A1GAASLC6A2SLC6A4DRD1 | |
| SCHEMBL25674512 | 0.77 | ALDH1A1 (0.33) | ALDH1A1GAASLC6A2SLC6A4DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192671-A1 | COMPOUNDS FOR THE TREATMENT OF SARS | PURDUE RESEARCH FOUNDATION | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192671-A1 | COMPOUNDS FOR THE TREATMENT OF SARS | ACE2, ACE, SARS1 | ALDH1A1 3093/4885GAA 731/4885SLC6A2 4007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.